US FDA extends review period for expanded use of Abbvie’s psoriasis drug
The US Food and Drug Administration (FDA) was reviewing the application for the use of Skyrizi in patients aged 16 years or older…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
psoriasis drug
US FDA approves expanded use of Amgen’s psoriasis drug
The drug is already approved for three indications, including to treat patients with moderate-to-severe plaque psoriasis and…
Lipidor and Cadila Pharma strike partnership for psoriasis drug candidate’s phase III clinical…
The Phase III study is expected to involve 270 patients and will be conducted in India on patients with various skin types
New data fuel hopes for broad use of Novartis psoriasis drug
Novartis is increasingly confident about the potential of its new injectable drug Cosentyx, as fresh clinical data confirms its…